Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xylometazoline Decongestant Effect in Common Cold
NCT00452270Phase 3Completed
- Sponsor
- Novartis
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of xylometazoline in common cold, sponsored by Novartis. Started Mar 2007; status: completed.
02
Drugs
xylometazoline
03
Conditions
common cold
Beyond the preview
Go deeper on NCT00452270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00452270.